Industry-Sponsored Research Week

U Queensland enters collaboration with Pfizer in search of cancer therapy


By David Schwartz
Published: June 11th, 2019

UniQuest, The University of Queensland’s commercialization company, has struck up a partnership with Pfizer’s Centers for Therapeutic Innovation (CTI) in hopes of developing a drug candidate for cancer treatment.

UQ Vice-Chancellor and President Professor Peter Høj said the collaboration, under which university researchers with work with Pfizer to create a potential first-in-class cancer drug, came about as a result of UQ’s excellence in research.

“We are very pleased to combine UQ’s research expertise in cancer biology and immunology with Pfizer’s world class capability in drug discovery and development,” he said. “Industry collaborations such as this help to ensure that promising academic research has the best chance of generating potential life-changing treatments for those who need it most.”

UniQuest CEO Dr. Dean Moss said the UQ project was the first in Queensland to be funded under Pfizer’s CTI program, and only the second in Australia. “The alliance provides UQ researchers with the opportunity to closely collaborate with Pfizer’s industry-leading drug discovery and development capabilities with the aim of bringing new treatments to the market.”

Source: UQ News

Posted under: University-Industry Engagement Week

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment